Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Aromatase Inhibitors × Clear all

Status

Sponsor Class

OTHER 66 INDUSTRY 21 NIH 5 OTHER_GOV 4 UNKNOWN 1 NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Hormone Receptor Positive Advanced Breast Cancer 1

Interventions

Paclitaxel 20 Capecitabine 18 S 1 (combination) 17 Cisplatin 15 Oxaliplatin 11 Radiotherapy, Intensity-Modulated 9 apatinib 8 Epirubicin 8 Docetaxel 8 Carboplatin 8 Radiotherapy 7 Irinotecan 7 titanium silicide 6 sintilimab 6 pyrotinib 6 nimotuzumab 6 anlotinib 6 Drug Therapy 6 Albumin-Bound Paclitaxel 6 130-nm albumin-bound paclitaxel 6 nedaplatin 5 camrelizumab 5 Temozolomide 5 Etoposide 5 Bevacizumab 5 nabiximols 4 Vinorelbine 4 Trastuzumab 4 Radiation Dose Hypofractionation 4 Radiation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05000736 2022-04-29

CAPACITY

ChineseAMS

Hormone Receptor Positive Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡